Gene · 406967
Papers3,717
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 3,717
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Expression analysis of miR-93, miR-122, and miR-192 in patients with coronary artery disease. | Exp Gerontol | 2025 | 41093081 | PubTator, text mining | PubMed |
| A review of the literature on obesity-related chronic kidney disease: a molecular description of gene susceptibility to polymorphisms, noncoding RNAs, and pathophysiology. | Arch Med Sci | 2025 | 41078902 | PubTator, text mining | PubMed |
| HCV patients with residual fibrosis after DAA treatment re-establish their epigenetic signature after prolonged-release pirfenidone: MINERVA study. | Clin Epigenetics | 2025 | 41044745 | PubTator, text mining | PubMed |
| A circulating microRNA panel enhances the diagnosis of cholangiocarcinoma. | PLoS One | 2025 | 40996984 | PubTator, text mining | PubMed |
| Bio fluid exosomes: promises, challenges, and future directions in translational medicine. | J Transl Med | 2025 | 40988065 | PubTator, text mining | PubMed |
| Assessing the Biological Markers of MiRNA-9 and 192 Expression Levels in Cervical Cancer. | Adv Biomed Res | 2025 | 40958932 | PubTator, text mining | PubMed |
| The role and therapeutic potential of exosome-mediated microRNAs regulatory networks in diabetic kidney disease. | Mol Biol Rep | 2025 | 40944788 | PubTator, text mining | PubMed |
| The miR-192-EGR1/HOXB9 Loop Regulates Glioma Cell Stemness and Malignant Phenotypes by Promoting Their Mesenchymal Transition. | J Cell Mol Med | 2025 | 40936205 | PubTator, text mining | PubMed |
| Validation of plasma microRNAs as biomarkers in sepsis associated acute kidney injury upon first clinical presentation reveals limited diagnostic and prognostic performance. | PLoS One | 2025 | 40906653 | PubTator, text mining | PubMed |
| A Comparison of Novel Serum Markers of Liver Health in Adolescents With Metabolic Dysfunction-Associated Steatotic Liver Disease. | J Cell Mol Med | 2025 | 40874510 | PubTator, text mining | PubMed |
| Role of Exosomal miRNAs and Epigenetic Modifications in Diabetic Nephropathy: Insights into Novel Diagnostic and Therapeutic Strategies. | Curr Gene Ther | 2025 | 40873225 | PubTator, text mining | PubMed |
| Impact of Micro-RNAs as biomarkers for end-stage renal disease related to hypertension and diabetes. | Sci Rep | 2025 | 40851001 | PubTator, text mining | PubMed |
| Cold-induced hepatocyte-derived exosomes activate brown adipose thermogenesis via miR-293-5p-mediated transcriptional reprogramming. | Cell Death Discov | 2025 | 40846699 | PubTator, text mining | PubMed |
| MicroRNAs in long COVID: roles, diagnostic biomarker potential and detection. | Hum Genomics | 2025 | 40804645 | PubTator, text mining | PubMed |
| Integrative analysis of DEGs and regulatory networks in T2DM: identification of core genes and regulatory elements as novel therapeutic targets. | 3 Biotech | 2025 | 40787105 | PubTator, text mining | PubMed |
| Mechanisms and therapeutic strategies linking mesenchymal stem cells senescence to osteoporosis. | Front Endocrinol (Lausanne) | 2025 | 40761817 | PubTator, text mining | PubMed |
A GWAS Meta-meta-analysis and In-depth Silico Pharmacogenomic Investigations in Identification of APOE and Other Genes Associated with Pain, Anti-inflammatory, and Immunomodulating Agents in Opioid Use Disorder (OUD) Derived from 14.91 M Subjects. | Cell Mol Neurobiol | 2025 | 40742457 | PubTator, text mining | PubMed |
| Advances in mesenchymal stem cells and their derivatives for promoting peripheral nerve regeneration. | Burns Trauma | 2025 | 40740686 | PubTator, text mining | PubMed |
| Pathological Evolution and Internal Medicine Management of Nonalcoholic Fatty Liver Disease (NAFLD) in the Era of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). | Cureus | 2025 | 40734888 | PubTator, text mining | PubMed |
| What a Modern Physician Should Know About microRNAs in the Diagnosis and Treatment of Diabetic Kidney Disease. | Int J Mol Sci | 2025 | 40724919 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/406967/papers?page=3